AbbVie (ABBV) Prepaid Assets (2012 - 2026)

AbbVie (ABBV) posted quarterly Prepaid Assets of $6.6 billion for Q1 2026, up 20.27% YoY from $5.5 billion in Q1 2025, and up 5.04% sequentially from $6.3 billion in Q4 2025.

AbbVie (ABBV) Prepaid Assets (2012 - 2026) Analysis & Trends

AbbVie has disclosed Prepaid Assets across 15 years of filings, most recently posting $6.6 billion for Q1 2026.

  • In Q1 2026, Prepaid Assets rose 20.27% year-over-year to $6.6 billion; the TTM figure through Mar 2026 stood at $6.6 billion (up 20.27% YoY), while the FY2025 annual figure was $6.3 billion, up 27.72% from the prior year.
  • Prepaid Assets grew to $6.6 billion in Q1 2026, from $6.3 billion in the prior quarter.
  • Over the last five years, Prepaid Assets for ABBV reached as high as $6.6 billion in Q1 2026 and fell as low as $4.4 billion in Q4 2022.
  • The 5-year median for Prepaid Assets is $4.7 billion (2024), against an average of $5.0 billion.
  • Annual changes were most pronounced in 2022 — Prepaid Assets dropped 11.86% — and 2025, when it climbed 27.72%.
  • A 5-year view of Prepaid Assets shows it stood at $4.4 billion in 2022, then gained by 12.07% to $4.9 billion in 2023, then declined by 0.1% to $4.9 billion in 2024, then advanced by 27.72% to $6.3 billion in 2025, then climbed by 5.04% to $6.6 billion in 2026.
  • According to Business Quant data, Prepaid Assets over the past three periods registered $6.6 billion, $6.3 billion, and $5.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.61 Bn
Dec 31, 2025 6.29 Bn
Sep 30, 2025 5.16 Bn
Jun 30, 2025 5.20 Bn
Mar 31, 2025 5.50 Bn
Dec 31, 2024 4.93 Bn
Sep 30, 2024 4.58 Bn
Jun 30, 2024 4.72 Bn
Mar 31, 2024 4.61 Bn
Dec 31, 2023 4.93 Bn
Sep 30, 2023 4.54 Bn
Jun 30, 2023 4.54 Bn
Mar 31, 2023 4.46 Bn
Dec 31, 2022 4.40 Bn
Sep 30, 2022 4.57 Bn
Jun 30, 2022 4.51 Bn
Mar 31, 2022 4.72 Bn
Dec 31, 2021 4.99 Bn
Sep 30, 2021 4.33 Bn
Jun 30, 2021 4.10 Bn